Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2013
05/02/2013CA2853440A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013CA2853401A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
05/02/2013CA2853366A1 Quinolines as fgfr kinase modulators
05/02/2013CA2853231A1 Pyridazine derivatives useful in therapy
05/02/2013CA2853227A1 Azole derivative
05/02/2013CA2853221A1 Bicyclic compound
05/02/2013CA2853062A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
05/02/2013CA2851930A1 Novel pyrazine derivatives
05/02/2013CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/01/2013EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors
05/01/2013EP2585458A1 Alkaloid aminoester derivatives and medicinal composition thereof
05/01/2013EP2585452A1 Process for the preparation of propionic acid derivatives
05/01/2013EP2585447A2 Compounds and methods for the treatment or prevention of flavivirus infections
05/01/2013EP2585444A1 Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
05/01/2013EP2585443A1 Process for producing imine compounds for combating invertebrate pests
05/01/2013CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
05/01/2013CN103080096A Bisaryl (thio)morpholine derivatives as S1P modulators
05/01/2013CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders
05/01/2013CN103080086A Prostaglandin D synthase inhibitory piperidine compounds
05/01/2013CN103079566A Heterocyclyl compounds as histamine H3 receptor ligands
05/01/2013CN103079564A Therapeutic agent for pain
05/01/2013CN101809005B Fused bicyclic compound
05/01/2013CN101679270B Dihydroquinone and dihydronaphthridine inhibitors of JNK
04/2013
04/30/2013US8431695 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
04/30/2013US8431694 Process for making thienopyrimidine compounds
04/30/2013US8431579 Capped pyrazinoylguanidine sodium channel blockers
04/30/2013US8431574 Heterocyclic inhibitors of MEK and methods of use thereof
04/30/2013US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
04/30/2013CA2687614C Methods for preparing diazonamides
04/30/2013CA2595834C Pyrazolylaminopyridine derivatives useful as kinase inhibitors
04/30/2013CA2579199C Substituted isoxazoles as fungicides
04/30/2013CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors
04/30/2013CA2431483C Antiviral agents
04/25/2013WO2013059788A1 Process for preparing quinoline derivatives
04/25/2013WO2013059677A1 Compounds that modulate intracellular calcium
04/25/2013WO2013059222A1 2-pyridyloxy-4-nitrile orexin receptor antagonists
04/25/2013WO2013058258A1 Bicyclic heterocyclic compound
04/25/2013WO2013058256A1 Nitrogenated heterocyclic compound, and bactericidal agent for agricultural and horticultural purposes
04/25/2013WO2013057711A1 Quinazoline derivatives as pi3k modulators
04/25/2013WO2013057251A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
04/25/2013WO2013057123A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids
04/25/2013WO2013057101A1 Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitors
04/25/2013WO2013057013A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
04/25/2013WO2013056679A1 Novel heteroaryl-amino derivatives
04/25/2013WO2013005168A3 Cannabinoid receptor modulators
04/25/2013WO2012122340A8 Soluble guanylate cyclase activators
04/25/2013US20130102783 Substituted diketopiperazines and their use as oxytocin antagonists
04/25/2013US20130102778 Process for the preparation of isoxazolyl- methoxy nicotinic acids
04/25/2013US20130102776 Anticancer agent
04/25/2013US20130102633 Transglutaminase inhibitors and methods of use thereof
04/25/2013US20130102632 Substituted heterocyclic compounds as ion channel modulators
04/25/2013US20130102629 Analogues for the treatment or prevention of flavivirus infections
04/25/2013US20130102617 Method of treating diabetes, metabolic syndrome and obesity using phenylacetamide derivative
04/25/2013US20130102607 Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections
04/25/2013US20130102604 Novel cyclopropane indolinone derivatives
04/25/2013US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions
04/25/2013US20130102600 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
04/25/2013US20130102598 Indenoquinolone compound, preparation method and use thereof
04/25/2013US20130102597 Compounds and methods for treating inflammatory and fibrotic disorders
04/25/2013US20130102592 Oxazole tyrosine kinase inhibitors
04/25/2013US20130102576 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
04/25/2013US20130102568 Alkoxyimino derivative and pest control agent
04/25/2013US20130102468 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
04/25/2013US20130102462 Process for Producing Imine Compounds for Combating Invertebrate Pests
04/25/2013US20130102014 Fluorinated resorufin compounds and their application
04/25/2013CA2852771A1 Process for preparing quinoline derivatives
04/25/2013CA2852750A1 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
04/25/2013CA2852723A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
04/25/2013CA2852425A1 2-pyridyloxy-4-nitrile orexin receptor antagonists
04/25/2013CA2851589A1 Bicyclic heterocyclic compound
04/25/2013CA2850440A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids
04/24/2013EP2583969A2 Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients
04/24/2013EP2583968A1 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses
04/24/2013EP2583965A1 Heterocyclic ring compound
04/24/2013EP2582698A1 Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
04/24/2013EP2582697A1 Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
04/24/2013EP2582696A1 5-aryl isoxazolines for controlling pests
04/24/2013EP2582692A1 Cyclohexyl-azetidinyl antagonists of ccr2
04/24/2013EP2582691A1 Anthranilic acid derivatives
04/24/2013EP2582688A1 Anthranilic acid diamide derivatives
04/24/2013EP2582432A1 Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (rsv) infection
04/24/2013CN103068821A 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
04/24/2013CN103068814A 邻氨基苯甲酸衍生物 Anthranilic acid derivatives
04/24/2013CN103068813A Anthranilic acid diamide derivatives
04/24/2013CN103068806A 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
04/24/2013CN103068798A Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
04/24/2013CN103068797A Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
04/24/2013CN103068391A Morpholino pyrimidines and their use in therapy
04/24/2013CN103059014A Novel heteroaryl amino derivative
04/24/2013CN103059012A 1,8-dicarbonyl-4,5-epoxy compound and preparation method thereof
04/24/2013CN103059011A Three metal organic frames based on Co(II) ion as well as synthesis method and application thereof
04/24/2013CN103059010A 1,4-benzoxazinone-1,2,3-triazole compound having antifungal activity, and its preparation method
04/24/2013CN103059009A 4-nitro-3-(5-tetrazole) furoxan energetic ionic salt and preparation method thereof
04/24/2013CN102086194B Synthesis method of furazolidone
04/24/2013CN102070525B Tetrahydroisoquinoline derivatives and preparation method and application thereof
04/24/2013CN101735210B N-substituted oxadiazine compounds with insecticidal and bactericidal activities, preparation method thereof and use thereof
04/24/2013CN101720325B Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
04/24/2013CN101282968B Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
04/23/2013US8426585 Compounds comprising a spiro-ring
04/23/2013US8426447 Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 647